Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAAGATCTA| |CAGCATGGGGCAGAATCTTTCCACCAGCAATCCTCTGGGATTCTTTCCCGACCACCAGTTGGATCCAGCCTTCAGAGCAAACACCGCAAATCCAGATTGG
End
59102607/58591240 (Hg38)
Nearest miRNA
hsa-let-7e/Upstream/40864;
Upstream sequence
CATACCACTCAGAGGGAATGCAAGATACATATTGACATCTCCTTTAGGATGTCCATAGAGAATTCAAGAAAAGAAATAATTTAAAAGTGCTTTTGGGTAC
Downstream sequence
AGCTATTTAGCACTAGAGGGTAAGAGTAGAGATAGATTGTAAAGATAATAAtagggttaggcataggattaggatctgggtcagagtcagggctggaagt
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.